Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Self-citationGriffith, O. W. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90139-6 · Cited by 4,602
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
[37] Carbonyl assays for determination of oxidatively modified proteins
Levine, R. L., Williams, J. A., Stadtman, E. P., & Shacter, E. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33040-9 · Cited by 2,699
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase
Deng, H.-X., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,477
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Cardiac Malformation in Neonatal Mice Lacking Connexin43
Reaume, A. G., de Sousa, P. A., Kulkarni, S., Langille, B. L., Zhu, D., Davies, T. C., Juneja, S. C., Kidder, G. M., & Rossant, J. (1995) · Science · doi:10.1126/science.7892609 · Cited by 1,244
Self-citationFridovich, I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83102-7 · Cited by 964
Cited by
Items 101–179 of 179
Protein Misfolding and Human Disease
Gregersen, N., Bross, P., Vang, S., & Christensen, J. H. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115737 · Cited by 301
Choi, J., Rees, H. D., Weintraub, S. T., Levey, A. I., Chin, L.-S., & Li, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414327200 · Cited by 291
Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury
Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J., & Appel, S. H. (2010) · Glia · doi:10.1002/glia.20919 · Cited by 288
Bruijn, L. I., Beal, M. F., Becher, M. W., Schulz, J. B., Wong, P. C., Price, D. L., & Cleveland, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7606 · Cited by 288
Self-citationNeurofilaments in Health and Disease
Julien, J.-P., & Mushynski, W. E. (1998) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60823-5 · Cited by 282
Genetics of familial amyotrophic lateral sclerosis
Valdmanis, P. N., & Rouleau, G. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296811.19811.db · Cited by 281
Mitochondria and degenerative disorders
Orth, M., & Schapira, A. H. V. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1425 · Cited by 280
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models
McCampbell, A., Cole, T., Wegener, A. J., Tomassy, G. S., Setnicka, A., Farley, B. J., Schoch, K. M., Hoye, M. L., Shabsovich, M., Sun, L., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99081 · Cited by 279
“Second, loss of SOD1, while resulting in eventual motor neuron dysfunction, does not result in motor neuron death (3, 4).”
BackgroundMelov, S., Doctrow, S. R., Schneider, J. A., Haberson, J., Patel, M., Coskun, P. E., Huffman, K., Wallace, D. C., & Malfroy, B. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08348.2001 · Cited by 277
Yoshihara, T., Ishigaki, S., Yamamoto, M., Liang, Y., Jun, Niwa, I., Takeuchi, H., Doyu, M., & Sobue, G. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00683.x · Cited by 275
Furukawa, Y., & O'Halloran, T. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500482200 · Cited by 275
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria
Vande Velde, C., Miller, T. M., Cashman, N. R., & Cleveland, D. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712209105 · Cited by 274
On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies
Muscoli, C., Cuzzocrea, S., Riley, D. P., Zweier, J. L., Thiemermann, C., Wang, Z., & Salvemini, D. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705430 · Cited by 271
“The importance of SOD2 is highlighted by the findings that, in contrast to SOD1 (Reaume et al., 1996) and SOD3 (Carlsson et al., 1995), the SOD2 knockout is lethal to mice (Li et al., 1995; Lebovitz et al., 1996; Melov et al., 1999).”
BackgroundInfluentialThe Copper Chaperone CCS Directly Interacts with Copper/Zinc Superoxide Dismutase
Casareno, R. L. B., Waggoner, D., & Gitlin, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23625 · Cited by 270
Jaarsma, D., Rognoni, F., van Duijn, W., Verspaget, H. W., Haasdijk, E. D., & Holstege, J. C. (2001) · Acta Neuropathologica · doi:10.1007/s004010100399 · Cited by 270
Kruman, I. I., Pedersen, W. A., Springer, J. E., & Mattson, M. P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7190 · Cited by 268
Mutant SOD1 causes motor neuron disease independent of copper chaperone–mediated copper loading
Subramaniam, J. R., Lyons, W. E., Liu, J., Bartnikas, T. B., Rothstein, J., Price, D. L., Cleveland, D. W., Gitlin, J. D., & Wong, P. C. (2002) · Nature Neuroscience · doi:10.1038/nn823 · Cited by 267
Bruening, W., Roy, J., Giasson, B., Figlewicz, D. A., Mushynski, W. E., & Durham, H. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720693.x · Cited by 263
Sod mimetics are coming of age
Salvemini, D., Riley, D. P., & Cuzzocrea, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd796 · Cited by 260
Awano, T., Johnson, G. S., Wade, C. M., Katz, M. L., Johnson, G. C., Taylor, J. F., Perloski, M., Biagi, T., Baranowska, I., Long, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812297106 · Cited by 260
Minute quantities of misfolded mutant superoxide dismutase‐1 cause amyotrophic lateral sclerosis
Jonsson, P. A., Ernhill, K., Andersen, P. M., Bergemalm, D., Brännström, T., Gredal, O., Nilsson, P., & Marklund, S. L. (2004) · Brain · doi:10.1093/brain/awh005 · Cited by 260
Genetic Neurodegenerative Diseases: The Human Illness and Transgenic Models
Price, D. L., Sisodia, S. S., & Borchelt, D. R. (1998) · Science · doi:10.1126/science.282.5391.1079 · Cited by 259
Mitochondrial involvement and oxidative stress in temporal lobe epilepsy
Rowley, S., & Patel, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.002 · Cited by 258
Juarez, J. C., Manuia, M., Burnett, M. E., Betancourt, O., Boivin, B., Shaw, D. E., Tonks, N. K., Mazar, A. P., & Doñate, F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709451105 · Cited by 257
Superoxide Dismutase Administration: A Review of Proposed Human Uses
Rosa, A. C., Corsi, D., Cavi, N., Bruni, N., & Dosio, F. (2021) · Molecules · doi:10.3390/molecules26071844 · Cited by 256
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease
Scott, J. L., Gabrielides, C., Davidson, R. K., Swingler, T. E., Clark, I. M., Wallis, G. A., Boot-Handford, R. P., Kirkwood, T. B. L., Talyor, R. W., & Young, D. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119966 · Cited by 255
Genetics of familial and sporadic amyotrophic lateral sclerosis
Gros-Louis, F., Gaspar, C., & Rouleau, G. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.01.004 · Cited by 255
How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?
SHAW, B., & VALENTINE, J. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.12.005 · Cited by 254
An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis
Rotunno, M. S., & Bosco, D. A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00253 · Cited by 245
“However, it is noted that SOD1 null mice are more susceptible to axonal (Reaume et al., 1996) and ischemic brain (Kondo et al., 1997) injuries, and therefore a complete loss of SOD1 may be disadvantageous, especially in the context of disease (van Blitterswijk et al., 2011).”
BackgroundBarja, G. (2004) · Biological Reviews · doi:10.1017/s1464793103006213 · Cited by 232
“Another study based on a larger number of mammalian species showed no correlation between brain, heart or liver SOD and MLSP (Tolmasoff et al., 1980) and in yet another no obvious relationship with MLSP was detectable for the overall levels of SOD, catalase and GSH-Px in liver, heart and brain of 4–6 mammals (Sohal, S…”
BackgroundInfluentialStructure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis
Rakhit, R., & Chakrabartty, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.004 · Cited by 232
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230
“Aβ: β-amyloid; AD: Alzheimer's disease; ADMA: Asymmetric dimethylarginine; ALS: Anterolateral sclerosis; APP: Precursor protein of β-amyloid; APP: Precursor protein; BACE2: β-amyloid cleavage enzyme 2; CBS: Cystathionine beta synthase; CNS: Central nervous system; DS: Down’s syndrome; DSCR: Down’s syndrome critical re…”
BackgroundKuo, J. J., Siddique, T., Fu, R., & Heckman, C. J. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.074138 · Cited by 225
“Despite nearly normal levels of SOD1 enzymatic activity, mutant SOD1 mice develop ALS, whereas SOD1 knockout mice do not (Gurney et al. 1994; Reaume et al. 1996; Wong et al. 2002).”
BackgroundTiwari, A., & Hayward, L. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210419200 · Cited by 224
Furukawa, Y., Fu, R., Deng, H.-X., Siddique, T., & O'Halloran, T. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602048103 · Cited by 224
Increased autophagy in transgenic mice with a G93A mutant SOD1 gene
Morimoto, N., Nagai, M., Ohta, Y., Miyazaki, K., Kurata, T., Morimoto, M., Murakami, T., Takehisa, Y., Ikeda, Y., Kamiya, T., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.045 · Cited by 223
Kabuta, T., Suzuki, Y., & Wada, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603337200 · Cited by 219
Ohlemiller, K. K., McFadden, S. L., Ding, D.-L., Flood, D. G., Reaume, A. G., Hoffman, E. K., Scott, R. W., Wright, J. S., Putcha, G. V., & Salvi, R. J. (1999) · Audiology and Neurotology · doi:10.1159/000013847 · Cited by 218
“KO (n = 15), heterozygous (Het, n = 29) and wild-type mice (WT, n = 15) for the normal Sod1 gene were produced by heterozygous matings, the original mating pairs having been obtained from Cephalon (West Chester, Pa., USA) [Reaume et al., 1996].”
BackgroundMethodSelf-citationNeuronal Apoptosis in Neurodegeneration
Okouchi, M., Ekshyyan, O., Maracine, M., & Aw, T. Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1511 · Cited by 218
“Moreover, SOD-deficient mice develop normally and exhibit no evidence of motor neuron cell death by 6 months of age (303), while mice carrying the familial ALS mutation SOD1 G93A exhibit motor neuron degeneration beginning at 3–5 months of age (122).”
Endogenous oxidative stress: relationship to aging, longevity and caloric restriction
Barja, G. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00008-9 · Cited by 215
Kerman, A., Liu, H.-N., Croul, S., Bilbao, J., Rogaeva, E., Zinman, L., Robertson, J., & Chakrabartty, A. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0646-5 · Cited by 205
“Furthermore, SOD1 knock-out mice do not develop motor neuron degeneration [32].”
BackgroundBonafede, R., & Mariotti, R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00080 · Cited by 204
“Since the complete absence of the SOD1 gene does not cause the disease in mice (Reaume et al., 1996), the SOD1 gene silencing has been regarded as an interesting possibility to limit the course of the pathology.”
BackgroundALS Mutants of Human Superoxide Dismutase Form Fibrous Aggregates Via Framework Destabilization
DiDonato, M., Craig, L., Huff, M. E., Thayer, M. M., Cardoso, R. M. F., Kassmann, C. J., Lo, T. P., Bruns, C. K., Powers, E. T., Kelly, J. W., et al. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00889-1 · Cited by 203
Ghadge, G. D., Lee, J. P., Bindokas, V. P., Jordan, J., Ma, L., Miller, R. J., & Roos, R. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-22-08756.1997 · Cited by 197
“The latter hypothesis was also supported by studies demonstrating the viability of motor neurons in SOD knock-out mice (Reaume et al., 1996).”
BackgroundResultInfluentialSuperoxide dismutase and the death of motoneurons in ALS
Beckman, J. S., Estévez, A. G., Crow, J. P., & Barbeito, L. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01981-0 · Cited by 196
Wang, J., Xu, G., & Borchelt, D. R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0471 · Cited by 196
“SOD1, a homodimeric enzyme, is the principal superoxide scavenging activity of the cytoplasm (McCord et al., 1969; Reaume et al., 1996).”
BackgroundMouse models of human disease. Part II: recent progress and future directions.
Bedell, M. A., Largaespada, D. A., Jenkins, N. A., & Copeland, N. G. (1997) · Genes & Development · doi:10.1101/gad.11.1.11 · Cited by 195
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Zufiría, M., Gil-Bea, F. J., Fernández-Torrón, R., Poza, J. J., Muñoz-Blanco, J. L., Rojas-García, R., Riancho, J., & López de Munain, A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.004 · Cited by 194
Muller, F. (2000) · AGE · doi:10.1007/s11357-000-0022-9 · Cited by 193
“'s are superficially healthy although, on closer inspection, they do appear to have significant defects (13-15, 61-63) indicating that there is some physiological role for these enzymes.”
BackgroundExcitotoxicity and Amyotrophic Lateral Sclerosis
van Cutsem, P., Dewil, M., Robberecht, W., & van den Bosch, L. (2005) · Neurodegenerative Diseases · doi:10.1159/000089620 · Cited by 192
Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190
“This is equally important because SOD1 knockout mice do not develop motor neuron disease and have a normal lifespan (Reaume et al., 1996), but SOD2 knockout mice die shortly after birth (Leibovitz and Siegel, 1980) due to increased oxidative stress.”
Age-related cochlear hair cell loss is enhanced in mice lacking copper/zinc superoxide dismutase
McFadden, S. L., Ding, D., Reaume, A. G., Flood, D. G., & Salvi, R. J. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00018-4 · Cited by 188
Self-citationA Model of Plasma-Biofilm and Plasma-Tissue Interactions at Ambient Pressure
Chen, C., Liu, D. X., Liu, Z. C., Yang, A. J., Chen, H. L., Shama, G., & Kong, M. G. (2014) · Plasma Chemistry and Plasma Processing · doi:10.1007/s11090-014-9545-1 · Cited by 187
Hyperexcitability of Cultured Spinal Motoneurons From Presymptomatic ALS Mice
Kuo, J. J., Schonewille, M., Siddique, T., Schults, A. N. A., Fu, R., Bär, P. R., Anelli, R., Heckman, C. J., & Kroese, A. B. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00665.2003 · Cited by 185
“Studies using these transgenic mice and SOD1 knockout mice suggest that the motoneuron degeneration does not result from a loss of SOD1 enzyme activity, but from a toxic effect induced by the presence of mutant SOD1 itself (“toxic gain-of-function”; Gurney et al. 1994; Reaume et al. 1996; Wong et al. 2002).”
BackgroundLyons, T. J., Liu, H., Goto, J. J., Nersissian, A., Roe, J. A., Graden, J. A., Café, C., Ellerby, L. M., Bredesen, D. E., Gralla, E. B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12240 · Cited by 182
Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS
Karch, C. M., Prudencio, M., Winkler, D. D., Hart, P. J., & Borchelt, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902505106 · Cited by 182
“Because some SOD1 mutants retain high activity (5), and because the targeted deletion of SOD1 in mice does not induce ALS-like symptoms (6), mutant SOD1 is proposed to cause disease by the acquisition of toxic properties.”
BackgroundRatovitski, T., Corson, L. B., Strain, J., Wong, P., Cleveland, D. W., Culotta, V. C., & Borchelt, D. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1451 · Cited by 180
“For example, the targeted deletion of sod1 in mice does not lead to developmental defects or cause motor neuron disease ( 14 ).”
BackgroundThe Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
“Not only do many FALS mutants retain enzymatic activity at or near wild-type levels, but SOD1 null mice do not exhibit neurodegeneration.(50) Furthermore, the toxicity of SOD1 mutants”
Protein aggregation and neurodegenerative diseases: From theory to therapy
Kumar, V., Sami, N., Kashav, T., Islam, A., Ahmad, F., & Hassan, M. I. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.054 · Cited by 174
Mitochondrial ROS Metabolism: Modulation by Uncoupling Proteins
Casteilla, L., Rigoulet, M., & Pénicaud, L. (2001) · IUBMB Life · doi:10.1080/15216540152845984 · Cited by 172
Mitochondrial oxidative stress and increased seizure susceptibility in Sod2−/+ mice
Liang, L.-P., & Patel, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.029 · Cited by 169
Motor unit number estimation in human neurological diseases and animal models
Shefner, J. M. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00520-x · Cited by 167
Superoxide-Mediated Cytotoxicity in Superoxide Dismutase-Deficient Fetal Fibroblasts
Huang, T.-T., Yasunami, M., Carlson, E. J., Gillespie, A. M., Reaume, A. G., Hoffman, E. K., Chan, P. H., Scott, R. W., & Epstein, C. J. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0237 · Cited by 167
Self-citationAggregation of Copper–Zinc Superoxide Dismutase in Familial and Sporadic ALS
Chattopadhyay, M., & Valentine, J. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2536 · Cited by 163
Mitochondrial Oxidative Stress: Physiologic Consequences and Potential for a Role in Aging
MELOV, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06649.x · Cited by 161
Martin, L. J., Chen, K., & Liu, Z. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0911-05.2005 · Cited by 161
“SOD1 has antiapoptotic functions in cultured neurons (Greenlund et al., 1995), and MNs deficient in SOD1 have enhanced vulnerability to axotomy (Reaume et al., 1996).”
BackgroundAmyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Genetic epidemiology of amyotrophic lateral sclerosis
Majoor‐Krakauer, D., Willems, P., & Hofman, A. (2003) · Clinical Genetics · doi:10.1046/j.0009-9163.2002.00001.x · Cited by 147
Mitochondrial oxidative stress causes chromosomal instability of mouse embryonic fibroblasts
Samper, E., Nicholls, D. G., & Melov, S. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00062.x · Cited by 108
Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
A review of creatine supplementation in age-related diseases: more than a supplement for athletes
Smith, R. N., Agharkar, A. S., & Gonzales, E. B. (2014) · F1000Research · doi:10.12688/f1000research.5218.1 · Cited by 82
Stoccoro, A., Mosca, L., Carnicelli, V., Cavallari, U., Lunetta, C., Marocchi, A., Migliore, L., & Coppedè, F. (2018) · Epigenomics · doi:10.2217/epi-2018-0072 · Cited by 80
Schnabel, D., Salas-Vidal, E., Narváez, V., del Rayo Sánchez-Carbente, M., Hernández-García, D., Cuervo, R., & Covarrubias, L. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.12.023 · Cited by 78
The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells
Lewis, C.-A., Manning, J., Rossi, F., & Krieger, C. (2012) · Neurology Research International · doi:10.1155/2012/803701 · Cited by 76
The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
Obrenovich, M., Jaworski, H., Tadimalla, T., Mistry, A., Sykes, L., Perry, G., & Bonomo, R. (2020) · Microorganisms · doi:10.3390/microorganisms8050784 · Cited by 62
“The pre-synaptic glutamate transporter, GLT-1, clears most of the glutamate released in the cortex and hippocampus [63] and enhancing its expression improve neurological outcomes [64].”
BackgroundOpen-minded scepticism: inferring the causal mechanisms of human ageing from genetic perturbations
de Magalhães, J. P. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2004.05.003 · Cited by 54
“In several cases, animals do not show any differences in their ageing phenotype when compared to controls (Reaume et al., 1996; Ho et al., 1997; Schriner et al., 2000).”
Iuchi, Y., Okada, F., Takamiya, R., Kibe, N., Tsunoda, S., Nakajima, O., Toyoda, K., Nagae, R., Suematsu, M., Soga, T., et al. (2009) · Biochemical Journal · doi:10.1042/bj20090176 · Cited by 45
“However, acceleration of the pathological condition induced by interventions, such as ischemia and reperfusion, in many organs of SOD1 mice is more severe than in organs of SOD1 mice [8-10].”
Background
Metadata
- Authors
- Reaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. R., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H., Scott, R. W., & Snider, W. D.
- Venue
- Nature Genetics
- Published
- 1996-05
- Volume
- 13
- Issue
- 1
- Pages
- 43-47
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2072978915
- Cited by
- 1,292
- References
- 23
- FWCI
- 36.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.